Press Releases Archives - Page 2 of 2

Eikon Therapeutics Announces the Election of Robert L. Huffines to its Board of Directors

Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, announced today the appointment of Robert (“Robbie”) L. Huffines as an independent director…

Eikon Therapeutics Announces Business Update Highlighting Pipeline and Clinical Development Progress

‍HAYWARD, Calif. – Eikon Therapeutics, Inc., which advances breakthrough therapeutics through the purposeful integration of engineering and science, announced today that it has completed the previously announced integration of TLR 7…

Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets and Announces Emerging Drug Development Pipeline

HAYWARD, Calif. – Eikon Therapeutics, Inc., a biotechnology company that is advancing breakthrough therapeutics through the purposeful integration of engineering and science, today announced it has acquired exclusive rights to multiple…

Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise

HAYWARD, Calif. – Eikon Therapeutics, Inc., a clinical stage biotechnology company that is advancing breakthrough therapeutics through the purposeful integration of engineering and science, today announced its Clinical Development organization. Under…

Eikon Therapeutics Expands its Discovery Labs with Second Location in Hayward, California

HAYWARD, Calif. – Today, Eikon Therapeutics officially opened its second location in Hayward, expanding the company’s footprint to scale its research and engineering infrastructure. Eikon is a biotechnology company that…